Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  New Zealand Stock Exchange  >  Oceania Healthcare Limited    OCA   NZOCAE0002S0


SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Australia shares snap four-day rally as virus outbreaks weigh

11/20/2020 | 01:17am EST

* Aussie benchmark gains 2.1% for the week

* South Australia lockdown to be eased earlier than planned

* Gold stocks extend losses to fourth day

Nov 20 (Reuters) - Australian shares closed a muted session lower on Friday, as losses in the prominent gold sector outweighed gains in financials, while investors held off big bets as major cities across the world reported virus outbreaks and shutdowns.

The resurgence of the virus globally comes just as travel restrictions are gradually being eased, and it is likely to dampen prospects of a broader reopening that would boost the recovery underway in many economies.

The benchmark S&P/ASX 200 index snapped a four-session winning streak to end 0.12% lower at 6,539.2 points. For the week, it added 2.1%.

"Without knowing how some of the macro events might play out, there's really nothing to give a lead in the market," said Brad Smoling, managing director at Smoling Stockbroking.

Smoling also pointed at Wall Street's subdued trading session on Thursday, and disappointment over U.S. Treasury Secretary Steven Mnuchin halting some of the Federal Reserve's pandemic emergency lending programs - which sent U.S futures lower.

In other news, authorities said that South Australia's drastic six-day coronavirus lockdown was triggered by a "lie", and that restrictions would be relaxed much earlier than previously planned.

The central bank raised concerns over the Australian stock exchange's trading systems, after nearly an entire session had to be abandoned earlier this week due to a software glitch, hitting investor sentiment further.

Gold stocks extended losses to a fourth day and have lost 6% over the week, as vaccine optimism kept demand for the safe-haven commodity muted. Index heavyweight Newcrest Mining , down 0.5%, was one of the top drags.

Conversely, financials closed higher for a fifth trading session, and logged weekly gains of over 6%, stoked by hopes of economic recovery on the back of an incoming vaccine.

Regis Healthcare, while not a part of ASX200, soared 24% after a buyout offer from its top shareholder and investment firm while shares of biopharma firm Mesoblast surged after a deal with Novartis to aid COVID-19 treatment.

In New Zealand, the benchmark S&P/NZX 50 index finished 0.9% lower at 12,441.81, brought down by shares of Oceania Healthcare and Genesis Energy each losing around 3%. (Reporting by Arundhati Dutta and Deepali Saxena in Bengaluru, Editing by Sherry Jacob-Phillips)

© Reuters 2020
Stocks mentioned in the article
ChangeLast1st jan.
AUSTRALIAN DOLLAR / US DOLLAR (AUD/USD) 0.03% 0.77132 Delayed Quote.0.20%
GENESIS ENERGY LIMITED -1.56% 3.79 End-of-day quote.4.55%
MESOBLAST LIMITED -1.22% 2.43 End-of-day quote.8.00%
NEWCREST MINING LIMITED -1.47% 26.76 End-of-day quote.3.80%
NOVARTIS AG 0.77% 86.66 Delayed Quote.2.73%
OCEANIA HEALTHCARE LIMITED 2.70% 1.52 End-of-day quote.4.83%
REGIS HEALTHCARE LIMITED 4.00% 1.82 End-of-day quote.-3.70%
S&P/ASX 200 0.36% 6824.7 Real-time Quote.3.24%
01:12aAustralia shares end at 11-month high as country approves Pfizer vaccine
01/21OCEANIA HEALTHCARE : Posts Higher Profit, Revenue in Fiscal H1 2020
2020Australia shares snap four-day rally as virus outbreaks weigh
2020Australian shares close lower as spiralling pandemic stokes recovery fears
2020Australia, NZ shares follow global markets lower as virus cases surge
2020Australian shares inch lower on virus, U.S. stimulus worries
2020Australia shares track Wall Street higher, set to snap 3-day losing streak
2020Australia shares edge higher on Santos' record quarterly production
2020Australia shares end higher tracking Wall Street gains, vaccine optimism
2020Australia shares rise as potential COVID-19 drug lifts confidence
More news
Sales 2021 261 M 188 M 188 M
Net income 2021 61,9 M 44,6 M 44,6 M
Net Debt 2021 330 M 238 M 238 M
P/E ratio 2021 15,6x
Yield 2021 2,45%
Capitalization 953 M 684 M 687 M
EV / Sales 2021 4,92x
EV / Sales 2022 4,38x
Nbr of Employees 2 800
Free-Float 92,4%
Duration : Period :
Oceania Healthcare Limited Technical Analysis Chart | OCA | NZOCAE0002S0 | MarketScreener
Technical analysis trends OCEANIA HEALTHCARE LIMITED
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus BUY
Number of Analysts 4
Average target price 1,44 NZD
Last Close Price 1,52 NZD
Spread / Highest target 8,55%
Spread / Average Target -5,59%
Spread / Lowest Target -18,4%
EPS Revisions
Managers and Directors
Earl Gasparich Chief Executive Officer
Elizabeth Mary Coutts Chairman
Brent Aaron Pattison Chief Financial Officer
Alan Raymond Isaac Independent Non-Executive Director
Kerry Leigh Prendergast Independent Non-Executive Director
Sector and Competitors